# FDA Inspection 1257703 - Taro Pharmaceuticals Inc. - September 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/8f4b6451-c55b-4bbe-b5c6-e93a6f7ba75e
Source feed: FDA_Inspections

> FDA Inspection 1257703 for Taro Pharmaceuticals Inc. on September 20, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257703
- Company Name: Taro Pharmaceuticals Inc.
- Inspection Date: 2024-09-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1312804 - 2026-03-27](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/e59f5915-8816-41de-8678-f56559c43897)
- [FDA Inspection 1312804 - 2026-03-27](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/f7aedf41-6b70-4664-bccc-0be298a7c401)
- [FDA Inspection 1257703 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/d29183ba-0f33-4829-a258-2920145d20b0)
- [FDA Inspection 1180887 - 2022-09-16](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/5f06f6fb-7c0a-44ca-8fd5-6aad610d4a0c)
- [FDA Inspection 1088553 - 2019-05-03](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/6c8456ba-f9bc-45c1-aab9-d88bf456c31a)

Company: https://www.keypedia.com/companies/taro-pharmaceuticals-inc/2072a3d5-a0ae-4bb7-9375-a6406a4fd768

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c